![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Biomarkers and patient eligibility for CAR T cell therapies in MM (Multiple Myeloma Hub) View |
![]() |
Biomarkers and patient eligibility for CAR T cell therapies in DLBCL (Multiple Myeloma Hub) View |
![]() |
Who is eligible for CAR-T therapy #myeloma (HealthTree University for Multiple Myeloma) View |
![]() |
Can a patient use a different CAR-T target after receiving BCMA directed therapy (HealthTree University for Multiple Myeloma) View |
![]() |
BCMA-CD38 bispecific CAR-T cells in R/R MM (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Case 4: BCMA-Targeted CAR T-Cell Therapy in Myeloma (Targeted Oncology) View |
![]() |
Predicting MRD outcomes in myeloma using machine learning (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
The role of the UK in multiple myeloma clinical trials (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Treatment Options For Frail Patients at Early Relapse | Paul Richardson, MD | IMS 2023 (HealthTree Foundation) View |
![]() |
Welcome and introductions (Lymphoma Hub) View |